Filing metadata

Accession number
0001209191-22-001731
Form type
Form 4
Filer
IRulya Therapeutics Inc.
CIK
CIK 1662774
Filed
Jan 05, 2022
Reporting period
Dec 14, 2021
Description
Insider transaction

Explore SEC Filings Hub